Gel4Med

Gel4Med is a privately held, early stage company based in Boston, Massachusetts. Currently employing 12 individuals, the company generates an annual revenue of $2.5 million. Gel4Med specializes in developing innovative therapeutic materials designed to address critical needs in soft tissue regeneration. Their primary focus is on a synthetic tissue scaffolding matrix that offers a novel approach to wound healing. This matrix aims to eliminate antibiotic-resistant bacteria from a variety of wounds – cutaneous, surgical, combat, and ocular – while simultaneously promoting tissue regeneration. What sets Gel4Med apart is their unique platform technology that avoids the use of exogenous antibiotics or biologics. This innovative approach presents a promising solution for combating the growing threat of antibiotic resistance while providing a safer and more effective means of promoting tissue repair. For more information about Gel4Med and their groundbreaking work in regenerative medicine, visit their website at gelformed.com.